Lung Marker Market Analysis, Recent Trends and Regional Growth Forecast 2021-2026


Posted June 22, 2021 by Marksmithimarc

Looking forward, IMARC Group expects the global lung marker market to grow at a CAGR of around 11% during the forecast period (2021-2026).

 
According to the latest report by IMARC Group, titled "Lung Marker Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026," the global lung marker market is expected to exhibit strong growth during 2021-2026. Lung markers are substances produced by tumor cells that are used for lung localization. They are produced in the body in response to cancer and are found in the urine, blood and stool of the patients. They are used during lung intervention procedures for providing information regarding the nature and condition of cancer. They also aid in diagnosing, predicting and monitoring the tumor for understanding the type of therapy required to treat the condition. Apart from this, they are used in numerous hospitals and other healthcare facilities in the diagnosis and treatment of pleural effusion and mesothelioma.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Get a sample copy of this Report: https://www.imarcgroup.com/lung-marker-market/requestsample

Global Lung Marker Market Trends:

The global market is primarily driven by the increasing prevalence of lung cancer and the high mortality rates associated with it. This has led the key players to heavily invest in research and development (R&D) for the introduction of an effective cure. Since lung markers form an indispensable component in lung localization, a significant increase in their demand has been registered. Along with this, there has been an increase in the occurrence of respiratory disorders on account of deteriorating air quality, unhealthy lifestyle preferences and high smoking rates among the masses. Furthermore, the growing geriatric population across the globe is vulnerable to develop acute respiratory disorders, which is propelling the demand for lung markers. Governments of several countries are also offering numerous healthcare benefits for the early diagnosis and pre-treatment of several chronic diseases, such as lung cancer, which is acting as another major growth-inducing factor. to grow at a CAGR of around 11% during the forecast period (2021-2026).

View Full Report with TOC & List of Figure: https://bit.ly/3gVx3CH
Competitive Landscape with Key players:

The report has also analysed the competitive landscape of the market with some of the key players being.

Abbott Diagnostics Ltd.
Affymetrix Inc.
Agilent Technologies Inc.
Beckman Coulter
Fujirebio US
Hologic Inc.
Roche
Siemens Healthineers
Thermo Fisher Scientific.
Veridex LLC
Lung Marker Market Segmentation:

Our report has categorized the market based on region, cancer type, marker type and end use industry.

Breakup by Cancer Type:

Non-Small Cell Lung Cancer (NSCLC)
Small Cell Lung Cancer (SCLC)
Breakup by Marker Type:

EGFR
EML4-ALK
KRAS
BRAF
Others
Breakup by End User:

Hospitals
Diagnostic Labs
Others
Breakup by Region:

North America (United States, Canada)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:

Market Performance (2015-2020)
Market Outlook (2021-2026)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By mark smith
Phone 6317911145
Business Address 30 N Gould St
Country United States
Categories Health
Tags lung marker market
Last Updated June 22, 2021